InQpharm

What InQpharm does

InQpharm is a privately-held B2B health-activating technology incubator and licensor that develops proprietary, clinically validated ingredient platforms and finished consumer health solutions for third-party marketing partners. Founded in 2004 (with operational roots traced to 2000) and headquartered in Kuala Lumpur, Malaysia, the company maintains regional offices in Abertillery, United Kingdom and Berlin, Germany, and employs 11-50 staff. Its technology portfolio is built around patented complexes including Litramine® IQP G-002AS (Opuntia ficus-indica fiber), Flaxseed mucilage IQP-LU-104, Xaludicin® (garlic-derived actives), PeptoMatrix™ (Swiss oral care biomatrix), Night Coach (sleep), and Allergy Protection, spanning the categories of weight management, gut health, allergies, sleep, oral health, cardiovascular and immune health.

The company generates revenue through technology licensing, royalty and co-development agreements with consumer health companies such as Herbalife Nutrition, Perrigo, Windstar Medical and Biomed, who embed InQpharm's technologies in 150+ exclusive and private-label SKUs distributed globally through pharmacy, drug/food, mass, practitioner and direct-selling channels across 55+ markets. Cumulative shipments include 100M+ weight management packs and 25M+ gut health units over the past decade, while newer platforms such as sleep (5M+ consumer units in two years) and a Pet Health Activation vertical launched in 2023 indicate active portfolio expansion. The business is differentiated by patent-protected compositions, gold-standard published clinical trials, medical-device classifications in key markets (notably Allergies and Gut Health), and direct influence over agronomy programmes at raw material sourcing partners.

Name

InQpharm

Legal name

InQpharm

Website

https://inqpharm.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

InQpharm is a privately-held, Malaysia-headquartered B2B licensor that develops patented health-activating technologies — including Litramine®, IQP-LU-104, Xaludicin® and PeptoMatrix™ — and licenses them to consumer health marketing partners across weight, gut, allergy, sleep, oral, cardiovascular, immune and pet health categories in 55+ markets.

Ownership category

akta.pro rank

Product category

Nutraceutical / Health-Activating Technology Licensing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Miscellaneous Chemical Products (2890)

akta.pro primary industry

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

Keywords

• Health-activating technologies
• Consumer health licensing
• Weight management ingredients
• Proprietary nutraceutical IP
• Self-care product development

Headquarters

HQ city

Kuala Lumpur

HQ country

Malaysia

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Technology Licensing and Co-development: InQpharm develops proprietary health-activating technologies and licenses them to consumer health companies for commercialization. They work as an extended team with marketing partners prior to and after commercialization, creating market-ready smart choices for marketeers.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

InQpharm is a B2B incubator and developer of proprietary, IP-protected, clinically validated health-activating technologies and solutions for the consumer health industry. It licenses patented platforms such as Litramine®, Flaxseed mucilage IQP-LU-104, PeptoMatrix™, Xaludicin®, Night Coach and its Allergy Protection technology to consumer health marketers worldwide, covering weight management, gut health, allergies, sleep, cardiovascular health, immune health, oral health, and pet health.

Product overview

InQpharm is an incubator and developer of self-care health-activating technologies and solutions. The company offers a comprehensive portfolio organized across multiple health focus areas: Weight Management (Litramine® IQP G-002AS and Flaxseed mucilage IQP-LU-104 with variants including Fat Binder, Carb Blocker, Fat Burner, and Fat Carb Sugar Blocker products), Gut Health (Reflux Control, Diarrhea Control, Constipation Control, IBS Control, and Bloating Control solutions), Allergies (Allergy Protection line for adults and kids), Sleep (Night Coach products), Oral Health (FREZZ range with Swiss PeptoMatrix™ technology), and Cardiovascular/Immune Health (Xaludicin® technology). The company also has an emerging Pet Health Activation vertical launching in 2023. These solutions are sold through pharmacy, food, drug, mass channels, practitioners, and direct selling organizations, with over 100M product packs shipped to 55 global markets in the past decade. InQpharm works with marketing partners including Herbalife Nutrition, Perrigo, Windstar Medical, and Biomed.

Differentiator

Problem solved

Functional benefit

Brands

• Litramine®: Natural fiber complex made from Opuntia ficus-indica for weight management and dietary fat intake management.
• IQP-LU-104 (Flaxseed mucilage)
• Xaludicin®
• FREZZ
• Night Coach
• Allergy Protection
• Gut Health Solutions

Products and services

• Litramine® IQP G-002AS (Weight Management Technology Platform) Patented natural fiber complex made from Opuntia ficus-indica and enriched with additional fibers, licensed to consumer health companies for weight management products that manage dietary fat intake and reduce body weight in overweight and obese patients; supported by gold standard published clinical trials.
• Flaxseed mucilage IQP-LU-104 (Weight Management Technology Platform) Patented composition of water-soluble dietary fibers licensed to consumer health companies for satiety-driven weight management; clinically shown to deliver three times more weight loss than dieting and exercise alone over twelve weeks.
• Xaludicin® Cardiovascular Health Solution Cardiovascular health product leveraging garlic-chemistry Xaludicin® technology synergistically enhanced with botanical actives, vitamins and minerals to support healthy blood pressure and cholesterol levels; licensed to consumer health marketers and classified as a dietary supplement.
• Xaludicin® Immune Health Solution Immune health product built on Xaludicin® technology synergistically enhanced with botanical actives, vitamins and minerals to restore, strengthen and maintain the body's natural defense mechanism; licensed to consumer health marketers.
• FREZZ Oral Health Range (PeptoMatrix™) Oral health range based on InQpharm's PeptoMatrix™ Swiss biomatrix technology that creates a stable biomatrix around sensitive teeth with high affinity to calcium and complementary action to fluoride; clinically proven to relieve dental hypersensitivity with regular use and includes liquid mouthwash, toothpaste, and solid-dose mouthwash formats.
• Night Coach Sleep Solution Natural sleep solution built on an exclusive composition of proprietary ingredients supported by a gold standard clinical trial; classified as a dietary supplement, available in Classic and Stick Sachet formats, and shipped as over 5M consumer units in the past two years.
• Allergy Protection (Adults and Kids) Non-drug allergy relief platform suitable for adults and children, backed by strong IP and gold standard published clinical trials, classified as a medical device in Europe and North America, and shipped as over 15M consumer units in the past decade; licensed to consumer health marketers.
• Gut Health Range Comprehensive gastrointestinal solutions range covering reflux, diarrhea, constipation, IBS, and bloating; classified as medical devices, dietary supplements, or traditional medicines and shipped as over 25M consumer units across more than 35 markets in the past decade; licensed to consumer health marketers.
• Pet Health Activation New business vertical extending InQpharm's health-activating technology model into pet health, developing solutions that support healthier and longer lives for pets and their owners; launched early 2023.

Quantifiable outcome

• Litramine® users experienced 3x more weight loss than with dieting and exercise alone, with subjects maintaining body weight for 24 weeks after initial weight loss.
• +3 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Six partnerships are on record, tiered core.

• Herbalife NutritioncoreGTM or Marketing PartnerHerbalife Nutrition is a flagship marketing partner that features InQpharm®'s innovative wellness solutions. Most recently, Herbalife launched Fat Release by Herbalife®, a new weight management product developed in partnership with InQpharm®.
• PerrigocoreGTM or Marketing PartnerPerrigo features InQpharm®'s innovative wellness solutions as part of their consumer health portfolio.
• Windstar MedicalcoreGTM or Marketing PartnerWindstar Medical features InQpharm®'s innovative wellness solutions in European markets.
• BiomedcoreGTM or Marketing PartnerBiomed features InQpharm®'s innovative wellness solutions.
• Raw Material Sourcing PartnerscoreStrategic or Co-development PartnerInQpharm collaborates with some of the finest raw material sourcing partners in the world and often has direct influence over their agronomy programmes to ensure safety, quality, sustainability, scalability and industry-leading costs.
• Manufacturing PartnerscoreStrategic or Co-development PartnerManufacturing partners serve as the extended workbench of InQpharm. Partners are regularly audited and the company works hand-in-hand to continuously improve processes to ensure efficiency and quality.

Scale indicators7 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Nexira: Developer of proprietary plant-based health and nutrition ingredients (fibers, botanical extracts) with clinical support, supplying consumer health brands globally — directly comparable ingredient/IP model.
• AB Biotics: Specializes in proprietary probiotic and health ingredient innovations with clinical evidence, licensing to consumer health and nutrition brands — analogous technology-innovation and B2B licensing playbook.
• Kemin Industries: Global ingredient manufacturer that develops proprietary, science-backed health-activating ingredients for human and animal nutrition and licenses them to consumer health companies — closely aligned business model and customer base to InQpharm.
• Provexis (now part of DSM-Firmenich): Health technology licensor that developed and patented fruitflow® and similar natural bioactive technologies, commercialized via partnerships — the closest historical analogue to InQpharm's IP-driven licensing model.

Emerging players

• Lallemand Health Solutions: Probiotic and microbial-based health ingredient specialist with documented clinical evidence and B2B licensing to supplement brands — overlaps with InQpharm's clinically-validated health-activation positioning.
• Gnosis by Lesaffre: Develops branded yeast and fermentation-derived nutritional ingredients with proprietary IP and clinical backing, sold B2B to nutraceutical brands — comparable specialty ingredient licensor model.

Broad incumbents

• DSM-Firmenich: Global nutrition and health ingredients major with a deep portfolio across vitamins, nutraceuticals and functional ingredients, including acquired Provexis assets — competes for the same licensing and supply relationships.
• ADM Health & Wellness: Major global nutrition and wellness ingredient platform offering flavors, proteins and functional ingredients to consumer health brands — broader incumbent serving overlapping customer segments.
• Glanbia Nutritionals: Large-scale nutrition ingredient and premix supplier serving consumer health brands across multiple categories — broader portfolio but overlapping customer base and ingredient innovation mandate.
• Cargill Health & Nutrition: Diversified global ingredient supplier with a health and nutrition division serving food, beverage and supplement customers — overlaps as upstream ingredient partner and competitor in similar categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InQpharm